| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.767 | 0.02 | 0.81 | Antiinflammatory | 0.806 0.014 DBMET02076 0.703 0.03 DBMET02077 0.767 0.02 DBMET02078 0.705 0.03 DBMET02079 0.81 0.014 DBMET02080 0.749 0.023 DBMET02081 0.692 0.032 DBMET02082 0.523 0.078 DBMET02083 0.654 0.04 DBMET02084 | DBMET02080 | |
| 0.748 | 0.004 | 0.748 | Immunosuppressant | 0.747 0.004 DBMET02076 0.714 0.005 DBMET02077 0.716 0.005 DBMET02078 0.679 0.005 DBMET02079 0.692 0.005 DBMET02080 0.656 0.007 DBMET02081 0.684 0.005 DBMET02082 0.655 0.007 DBMET02083 0.691 0.005 DBMET02084 | ||
| 0.637 | 0.027 | 0.758 | Transcription factor NF kappa B inhibitor | 0.693 0.021 DBMET02076 0.717 0.019 DBMET02077 0.678 0.023 DBMET02078 0.256 0.123 DBMET02079 0.758 0.016 DBMET02080 0.651 0.026 DBMET02081 0.711 0.019 DBMET02082 0.413 0.061 DBMET02083 0.441 0.055 DBMET02084 | DBMET02080 | |
| 0.609 | 0.047 | 0.762 | Apoptosis agonist | 0.557 0.059 DBMET02076 0.63 0.043 DBMET02077 0.544 0.062 DBMET02078 0.728 0.026 DBMET02080 0.369 0.129 DBMET02081 0.762 0.021 DBMET02082 0.487 0.078 DBMET02083 0.411 0.108 DBMET02084 | DBMET02082 | |
| 0.513 | 0.018 | 0.647 | Caspase 3 stimulant | 0.459 0.027 DBMET02076 0.536 0.016 DBMET02077 0.503 0.02 DBMET02078 0.25 0.112 DBMET02079 0.647 0.008 DBMET02080 0.328 0.067 DBMET02081 0.501 0.02 DBMET02082 0.309 0.074 DBMET02083 0.508 0.019 DBMET02084 | DBMET02080 | |
| 0.495 | 0.016 | 0.576 | Nitric oxide antagonist | 0.453 0.02 DBMET02076 0.48 0.017 DBMET02077 0.431 0.022 DBMET02078 0.242 0.054 DBMET02079 0.576 0.011 DBMET02080 0.392 0.026 DBMET02081 0.46 0.019 DBMET02082 0.311 0.038 DBMET02083 0.332 0.035 DBMET02084 | DBMET02080 | |
| 0.506 | 0.057 | 0.766 | Caspase 9 stimulant | 0.485 0.066 DBMET02076 0.383 0.122 DBMET02077 0.474 0.071 DBMET02078 0.432 0.093 DBMET02079 0.766 0.016 DBMET02080 0.392 0.116 DBMET02081 0.463 0.076 DBMET02082 0.42 0.099 DBMET02083 0.389 0.118 DBMET02084 | DBMET02080 | |
| 0.366 | 0.034 | 0.618 | Hypoglycemic | 0.363 0.035 DBMET02076 0.324 0.045 DBMET02077 0.406 0.027 DBMET02078 0.618 0.007 DBMET02079 0.188 0.125 DBMET02080 0.292 0.055 DBMET02081 0.378 0.032 DBMET02082 0.531 0.013 DBMET02083 0.542 0.012 DBMET02084 | DBMET02079 | |
| 0.371 | 0.041 | 0.516 | Antioxidant | 0.363 0.043 DBMET02076 0.356 0.045 DBMET02077 0.369 0.041 DBMET02078 0.203 0.111 DBMET02079 0.516 0.018 DBMET02080 0.19 0.122 DBMET02081 0.387 0.037 DBMET02082 0.17 0.142 DBMET02083 0.282 0.069 DBMET02084 | DBMET02080 | |
| 0.355 | 0.047 | 0.43 | Calcium channel activator | 0.3 0.091 DBMET02076 0.257 0.139 DBMET02077 0.306 0.086 DBMET02078 0.43 0.015 DBMET02079 0.368 0.039 DBMET02080 0.338 0.059 DBMET02081 0.234 0.166 DBMET02082 0.308 0.084 DBMET02083 0.261 0.134 DBMET02084 | DBMET02079 | |
| 0.37 | 0.091 | 0.478 | Antibacterial | 0.405 0.075 DBMET02076 0.467 0.051 DBMET02077 0.39 0.081 DBMET02078 0.405 0.074 DBMET02079 0.478 0.047 DBMET02080 0.281 0.15 DBMET02081 0.474 0.049 DBMET02082 0.324 0.118 DBMET02083 0.259 0.169 DBMET02084 | DBMET02080 | |
| 0.313 | 0.041 | 0.313 | Antimitotic | 0.22 0.074 DBMET02076 0.167 0.106 DBMET02077 0.243 0.062 DBMET02078 0.169 0.105 DBMET02081 0.207 0.08 DBMET02082 0.21 0.078 DBMET02083 0.258 0.057 DBMET02084 | ||
| 0.287 | 0.031 | 0.287 | P-glycoprotein inhibitor | 0.227 0.05 DBMET02076 0.186 0.075 DBMET02077 0.228 0.05 DBMET02078 0.142 0.13 DBMET02080 0.206 0.06 DBMET02081 0.217 0.054 DBMET02082 0.199 0.064 DBMET02083 0.271 0.035 DBMET02084 | ||
| 0.244 | 0.01 | 0.251 | Microtubule formation inhibitor | 0.24 0.011 DBMET02076 0.237 0.012 DBMET02077 0.251 0.008 DBMET02078 0.168 0.03 DBMET02079 0.242 0.011 DBMET02080 0.241 0.011 DBMET02081 0.241 0.011 DBMET02082 0.243 0.011 DBMET02083 0.238 0.012 DBMET02084 | DBMET02078 | |
| 0.264 | 0.045 | 0.605 | Platelet adhesion inhibitor | 0.136 0.123 DBMET02076 0.135 0.125 DBMET02077 0.149 0.106 DBMET02078 0.136 0.124 DBMET02080 0.605 0.004 DBMET02082 | DBMET02082 | |
| 0.221 | 0.005 | 0.483 | Prostaglandin EP2 antagonist | 0.188 0.007 DBMET02076 0.16 0.009 DBMET02077 0.233 0.005 DBMET02078 0.063 0.039 DBMET02079 0.483 0.003 DBMET02080 0.264 0.005 DBMET02081 0.206 0.006 DBMET02082 0.099 0.019 DBMET02083 0.251 0.005 DBMET02084 | DBMET02080 | |
| 0.267 | 0.062 | 0.404 | Free radical scavenger | 0.218 0.084 DBMET02076 0.205 0.094 DBMET02077 0.269 0.061 DBMET02078 0.404 0.028 DBMET02080 0.204 0.094 DBMET02081 0.285 0.056 DBMET02082 0.172 0.122 DBMET02084 | DBMET02080 | |
| 0.247 | 0.044 | 0.521 | Hepatoprotectant | 0.236 0.048 DBMET02076 0.28 0.035 DBMET02077 0.29 0.033 DBMET02078 0.304 0.028 DBMET02079 0.283 0.035 DBMET02080 0.245 0.045 DBMET02081 0.521 0.006 DBMET02082 0.227 0.051 DBMET02083 0.281 0.035 DBMET02084 | DBMET02082 | |
| 0.23 | 0.032 | 0.362 | Interferon gamma antagonist | 0.232 0.032 DBMET02076 0.169 0.058 DBMET02077 0.242 0.03 DBMET02078 0.244 0.029 DBMET02079 0.362 0.013 DBMET02080 0.191 0.044 DBMET02081 0.234 0.032 DBMET02082 0.156 0.071 DBMET02083 0.174 0.054 DBMET02084 | DBMET02080 | |
| 0.249 | 0.07 | 0.302 | Vasodilator | 0.19 0.113 DBMET02076 0.158 0.146 DBMET02077 0.205 0.101 DBMET02078 0.302 0.047 DBMET02080 0.209 0.098 DBMET02082 0.213 0.095 DBMET02084 | DBMET02080 | |
| 0.186 | 0.023 | 0.273 | Antineoplastic antibiotic | 0.173 0.026 DBMET02076 0.174 0.026 DBMET02077 0.161 0.029 DBMET02078 0.069 0.065 DBMET02079 0.273 0.012 DBMET02080 0.227 0.017 DBMET02081 0.164 0.028 DBMET02082 0.176 0.025 DBMET02083 0.156 0.03 DBMET02084 | DBMET02080 | |
| 0.271 | 0.11 | 0.52 | Antithrombotic | 0.283 0.1 DBMET02076 0.283 0.101 DBMET02077 0.487 0.031 DBMET02078 0.437 0.041 DBMET02079 0.461 0.036 DBMET02080 0.325 0.074 DBMET02081 0.52 0.026 DBMET02082 0.298 0.089 DBMET02083 0.464 0.035 DBMET02084 | DBMET02082 | |
| 0.191 | 0.032 | 0.215 | Protein-tyrosine phosphatase 1B inhibitor | 0.126 0.058 DBMET02076 0.115 0.067 DBMET02077 0.188 0.032 DBMET02078 0.194 0.031 DBMET02079 0.215 0.025 DBMET02080 0.188 0.033 DBMET02082 0.111 0.069 DBMET02084 | DBMET02080 | |
| 0.166 | 0.008 | 0.166 | Calcium channel L-type blocker | 0.147 0.01 DBMET02076 0.068 0.055 DBMET02077 0.086 0.034 DBMET02078 0.09 0.03 DBMET02079 | ||
| 0.252 | 0.095 | 0.352 | Immunostimulant | 0.352 0.064 DBMET02076 0.25 0.096 DBMET02077 0.291 0.081 DBMET02078 0.331 0.07 DBMET02079 0.268 0.089 DBMET02080 0.23 0.105 DBMET02081 0.298 0.079 DBMET02082 0.219 0.11 DBMET02083 0.352 0.064 DBMET02084 | DBMET02084 | |
| 0.158 | 0.005 | 0.231 | Neuraminidase inhibitor | 0.146 0.006 DBMET02076 0.126 0.009 DBMET02077 0.135 0.008 DBMET02078 0.231 0.004 DBMET02079 0.098 0.016 DBMET02080 0.127 0.009 DBMET02081 0.102 0.015 DBMET02082 0.088 0.02 DBMET02083 0.189 0.004 DBMET02084 | DBMET02079 | |
| 0.263 | 0.115 | 0.436 | Apoptosis antagonist | 0.337 0.062 DBMET02076 0.303 0.083 DBMET02077 0.327 0.068 DBMET02078 0.221 0.156 DBMET02079 0.436 0.03 DBMET02080 0.192 0.191 DBMET02081 0.366 0.049 DBMET02082 0.273 0.105 DBMET02083 0.304 0.083 DBMET02084 | DBMET02080 | |
| 0.16 | 0.013 | 0.193 | Anabolic | 0.151 0.017 DBMET02076 0.14 0.024 DBMET02077 0.158 0.014 DBMET02078 0.137 0.026 DBMET02079 0.193 0.005 DBMET02080 0.155 0.016 DBMET02081 0.147 0.02 DBMET02082 0.112 0.048 DBMET02083 0.12 0.039 DBMET02084 | DBMET02080 | |
| 0.186 | 0.047 | 0.367 | NOS3 expression enhancer | 0.159 0.064 DBMET02076 0.145 0.078 DBMET02077 0.173 0.054 DBMET02078 0.367 0.01 DBMET02080 0.162 0.062 DBMET02082 | DBMET02080 | |
| 0.163 | 0.024 | 0.201 | Papain-like protease (SARS coronavirus) inhibitor | 0.145 0.039 DBMET02076 0.152 0.032 DBMET02077 0.149 0.035 DBMET02078 0.201 0.01 DBMET02080 0.134 0.053 DBMET02082 | DBMET02080 | |
| 0.167 | 0.038 | 0.228 | Adenylate cyclase stimulant | 0.166 0.039 DBMET02076 0.13 0.103 DBMET02077 0.173 0.032 DBMET02078 0.182 0.024 DBMET02079 0.228 0.005 DBMET02080 0.184 0.023 DBMET02081 0.18 0.026 DBMET02082 0.155 0.055 DBMET02084 | DBMET02080 | |
| 0.135 | 0.02 | 0.151 | Transcription factor NF kappa B stimulant | 0.129 0.022 DBMET02076 0.113 0.029 DBMET02077 0.13 0.021 DBMET02078 0.085 0.059 DBMET02079 0.149 0.016 DBMET02080 0.1 0.039 DBMET02081 0.151 0.016 DBMET02082 0.081 0.067 DBMET02084 | DBMET02082 | |
| 0.172 | 0.061 | 0.236 | Protein-tyrosine phosphatase inhibitor | 0.125 0.108 DBMET02076 0.177 0.058 DBMET02078 0.202 0.046 DBMET02079 0.213 0.042 DBMET02080 0.236 0.035 DBMET02081 0.18 0.056 DBMET02082 | DBMET02081 | |
| 0.168 | 0.061 | 0.344 | Melanin inhibitor | 0.17 0.059 DBMET02076 0.176 0.055 DBMET02077 0.169 0.06 DBMET02078 0.164 0.064 DBMET02079 0.344 0.017 DBMET02080 0.156 0.074 DBMET02081 0.164 0.065 DBMET02082 0.137 0.102 DBMET02084 | DBMET02080 | |
| 0.166 | 0.07 | 0.226 | Arachidonic acid antagonist | 0.184 0.05 DBMET02076 0.181 0.053 DBMET02078 0.221 0.017 DBMET02079 0.226 0.014 DBMET02080 0.157 0.08 DBMET02081 0.152 0.086 DBMET02082 0.137 0.105 DBMET02083 0.168 0.067 DBMET02084 | DBMET02080 | |
| 0.108 | 0.012 | 0.11 | Androgen agonist | 0.098 0.015 DBMET02076 0.068 0.032 DBMET02077 0.094 0.017 DBMET02078 0.082 0.023 DBMET02079 0.11 0.012 DBMET02080 0.067 0.033 DBMET02081 0.074 0.028 DBMET02082 | DBMET02080 | |
| 0.103 | 0.017 | 0.168 | Estrogen agonist | 0.078 0.024 DBMET02076 0.063 0.029 DBMET02077 0.11 0.015 DBMET02078 0.168 0.01 DBMET02079 0.067 0.027 DBMET02080 0.085 0.021 DBMET02081 0.09 0.02 DBMET02082 0.102 0.017 DBMET02083 0.076 0.024 DBMET02084 | DBMET02079 | |
| 0.201 | 0.119 | 0.316 | Spasmolytic | 0.316 0.064 DBMET02076 0.178 0.138 DBMET02078 0.306 0.068 DBMET02080 0.185 0.133 DBMET02082 0.172 0.144 DBMET02084 | DBMET02076 | |
| 0.084 | 0.004 | 0.084 | Microtubule stabilization | 0.074 0.005 DBMET02076 0.075 0.005 DBMET02077 0.077 0.005 DBMET02078 0.044 0.035 DBMET02079 0.052 0.025 DBMET02080 0.074 0.005 DBMET02081 0.075 0.005 DBMET02082 0.075 0.005 DBMET02083 0.075 0.005 DBMET02084 | ||
| 0.125 | 0.046 | 0.167 | Estrogen antagonist | 0.119 0.056 DBMET02076 0.11 0.075 DBMET02077 0.121 0.053 DBMET02078 0.105 0.087 DBMET02079 0.167 0.018 DBMET02080 0.106 0.084 DBMET02082 | DBMET02080 | |
| 0.123 | 0.055 | 0.176 | TRPA1 agonist | 0.176 0.017 DBMET02077 0.104 0.08 DBMET02078 0.128 0.049 DBMET02079 0.13 0.047 DBMET02080 | DBMET02077 | |
| 0.097 | 0.029 | 0.129 | Estrogen receptor alpha antagonist | 0.083 0.044 DBMET02076 0.087 0.039 DBMET02078 0.083 0.043 DBMET02079 0.129 0.016 DBMET02080 | DBMET02080 | |
| 0.139 | 0.077 | 0.209 | Protein kinase stimulant | 0.153 0.066 DBMET02076 0.15 0.068 DBMET02078 0.209 0.038 DBMET02079 0.163 0.059 DBMET02080 0.17 0.055 DBMET02081 0.168 0.057 DBMET02082 0.161 0.061 DBMET02083 0.162 0.06 DBMET02084 | DBMET02079 | |
| 0.115 | 0.054 | 0.164 | Electron transport complex I inhibitor | 0.107 0.067 DBMET02076 0.096 0.091 DBMET02077 0.102 0.077 DBMET02078 0.164 0.015 DBMET02080 0.114 0.055 DBMET02084 | DBMET02080 | |
| 0.08 | 0.022 | 0.08 | Calcium channel T-type blocker | |||
| 0.065 | 0.01 | 0.067 | Squalene synthetase inhibitor | 0.043 0.017 DBMET02076 0.03 0.023 DBMET02077 0.055 0.013 DBMET02078 0.067 0.01 DBMET02079 0.064 0.011 DBMET02080 0.046 0.016 DBMET02082 | DBMET02079 | |
| 0.119 | 0.065 | 0.276 | Cholesterol synthesis inhibitor | 0.167 0.037 DBMET02076 0.152 0.044 DBMET02077 0.177 0.033 DBMET02078 0.276 0.014 DBMET02079 0.19 0.029 DBMET02080 0.199 0.027 DBMET02081 0.145 0.047 DBMET02082 0.117 0.068 DBMET02083 0.273 0.015 DBMET02084 | DBMET02079 | |
| 0.092 | 0.039 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 DBMET02076 0.114 0.02 DBMET02077 0.088 0.042 DBMET02078 0.111 0.022 DBMET02079 0.114 0.02 DBMET02080 0.086 0.045 DBMET02081 0.089 0.042 DBMET02082 0.088 0.043 DBMET02084 | DBMET02080 | |
| 0.125 | 0.072 | 0.157 | Cyclooxygenase 3 inhibitor | 0.124 0.073 DBMET02076 0.128 0.069 DBMET02078 0.141 0.056 DBMET02079 0.157 0.043 DBMET02080 0.11 0.089 DBMET02082 | DBMET02080 | |
| 0.066 | 0.019 | 0.083 | Pregnane X receptor antagonist | 0.061 0.028 DBMET02076 0.056 0.04 DBMET02077 0.061 0.028 DBMET02078 0.083 0.005 DBMET02079 0.08 0.007 DBMET02080 0.056 0.04 DBMET02083 | DBMET02079 | |
| 0.138 | 0.095 | 0.327 | Sigma receptor agonist | 0.327 0.034 DBMET02080 | DBMET02080 | |
| 0.123 | 0.081 | 0.162 | Vanilloid 1 agonist | 0.126 0.075 DBMET02076 0.125 0.077 DBMET02078 0.12 0.088 DBMET02079 0.162 0.028 DBMET02080 0.137 0.055 DBMET02082 | DBMET02080 | |
| 0.108 | 0.068 | 0.222 | Mucolytic | 0.123 0.051 DBMET02076 0.135 0.042 DBMET02078 0.155 0.03 DBMET02079 0.222 0.009 DBMET02080 0.101 0.077 DBMET02081 0.134 0.042 DBMET02082 0.107 0.069 DBMET02083 0.135 0.042 DBMET02084 | DBMET02080 | |
| 0.046 | 0.014 | 0.046 | RNA-directed RNA polymerase stimulant | 0.039 0.017 DBMET02076 0.038 0.017 DBMET02077 0.039 0.017 DBMET02078 0.03 0.021 DBMET02080 0.037 0.018 DBMET02081 0.034 0.019 DBMET02082 0.04 0.017 DBMET02083 0.037 0.017 DBMET02084 | ||
| 0.084 | 0.053 | 0.238 | T cell inhibitor | 0.078 0.073 DBMET02076 0.081 0.064 DBMET02078 0.238 0.006 DBMET02080 | DBMET02080 | |
| 0.066 | 0.038 | 0.081 | Nitric oxide donor | 0.065 0.04 DBMET02076 0.063 0.043 DBMET02078 0.081 0.022 DBMET02080 0.067 0.037 DBMET02082 0.061 0.048 DBMET02084 | DBMET02080 | |
| 0.06 | 0.031 | 0.06 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.195 | 0.169 | 0.655 | Cholesterol antagonist | 0.242 0.131 DBMET02076 0.399 0.049 DBMET02078 0.655 0.012 DBMET02079 0.391 0.051 DBMET02080 0.402 0.049 DBMET02081 0.412 0.047 DBMET02082 0.345 0.066 DBMET02083 0.519 0.03 DBMET02084 | DBMET02079 | |
| 0.085 | 0.061 | 0.172 | Ornithine decarboxylase inhibitor | 0.09 0.056 DBMET02076 0.083 0.064 DBMET02077 0.116 0.029 DBMET02078 0.172 0.007 DBMET02079 0.116 0.029 DBMET02080 0.109 0.035 DBMET02081 0.106 0.038 DBMET02082 0.087 0.059 DBMET02084 | DBMET02079 | |
| 0.08 | 0.057 | 0.137 | Glycine receptor antagonist | 0.115 0.021 DBMET02079 0.137 0.011 DBMET02080 | DBMET02080 | |
| 0.153 | 0.133 | 0.338 | Hypolipemic | 0.228 0.078 DBMET02078 0.338 0.038 DBMET02079 0.192 0.101 DBMET02080 0.17 0.118 DBMET02081 0.218 0.083 DBMET02082 0.252 0.066 DBMET02083 0.312 0.045 DBMET02084 | DBMET02079 | |
| 0.037 | 0.019 | 0.037 | Tubulin agonist | 0.034 0.025 DBMET02076 0.033 0.028 DBMET02077 0.035 0.023 DBMET02078 0.034 0.025 DBMET02079 0.032 0.029 DBMET02080 0.034 0.025 DBMET02081 0.033 0.028 DBMET02082 0.037 0.018 DBMET02083 0.034 0.023 DBMET02084 | ||
| 0.04 | 0.022 | 0.114 | Retinoid X receptor agonist | 0.04 0.022 DBMET02076 0.066 0.012 DBMET02078 0.114 0.004 DBMET02079 0.057 0.015 DBMET02080 0.044 0.021 DBMET02082 | DBMET02079 | |
| 0.029 | 0.014 | 0.047 | Retinoid X gamma receptor antagonist | 0.03 0.013 DBMET02076 0.026 0.02 DBMET02077 0.032 0.009 DBMET02078 0.047 0.004 DBMET02079 0.031 0.011 DBMET02081 0.03 0.012 DBMET02082 0.026 0.022 DBMET02083 0.027 0.019 DBMET02084 | DBMET02079 | |
| 0.033 | 0.019 | 0.133 | Prostaglandin EP3 antagonist | 0.026 0.025 DBMET02076 0.037 0.016 DBMET02078 0.133 0.005 DBMET02080 0.041 0.013 DBMET02081 0.037 0.015 DBMET02082 0.04 0.014 DBMET02084 | DBMET02080 | |
| 0.175 | 0.162 | 0.282 | DNA synthesis inhibitor | 0.195 0.13 DBMET02076 0.191 0.138 DBMET02077 0.189 0.14 DBMET02078 0.282 0.05 DBMET02079 0.263 0.059 DBMET02080 0.193 0.133 DBMET02081 0.233 0.08 DBMET02082 0.261 0.06 DBMET02083 0.271 0.055 DBMET02084 | DBMET02079 | |
| 0.037 | 0.026 | 0.054 | 5-Alpha-reductase inhibitor | 0.051 0.018 DBMET02078 0.051 0.018 DBMET02079 0.054 0.017 DBMET02080 | DBMET02080 | |
| 0.017 | 0.007 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.009 DBMET02076 0.015 0.011 DBMET02077 0.016 0.009 DBMET02078 0.016 0.007 DBMET02080 0.015 0.01 DBMET02081 0.015 0.01 DBMET02082 0.016 0.009 DBMET02083 0.015 0.009 DBMET02084 | ||
| 0.034 | 0.025 | 0.119 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET02076 0.055 0.013 DBMET02078 0.119 0.004 DBMET02079 0.051 0.014 DBMET02080 0.037 0.022 DBMET02082 | DBMET02079 | |
| 0.034 | 0.025 | 0.038 | HMG CoA reductase inhibitor | 0.035 0.023 DBMET02078 0.035 0.022 DBMET02079 0.035 0.023 DBMET02081 0.033 0.026 DBMET02082 0.038 0.017 DBMET02084 | DBMET02084 | |
| 0.024 | 0.015 | 0.114 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET02076 0.031 0.01 DBMET02078 0.114 0.003 DBMET02079 0.027 0.012 DBMET02081 0.026 0.013 DBMET02082 0.021 0.019 DBMET02083 | DBMET02079 | |
| 0.038 | 0.03 | 0.182 | Retinoic acid alpha receptor agonist | 0.042 0.023 DBMET02076 0.069 0.007 DBMET02078 0.182 0.003 DBMET02079 0.098 0.004 DBMET02081 0.062 0.009 DBMET02082 0.055 0.011 DBMET02083 0.058 0.01 DBMET02084 | DBMET02079 | |
| 0.012 | 0.007 | 0.021 | Calcineurin inhibitor | 0.011 0.008 DBMET02076 0.01 0.009 DBMET02077 0.012 0.007 DBMET02078 0.021 0.003 DBMET02080 0.012 0.007 DBMET02081 0.01 0.009 DBMET02082 | DBMET02080 | |
| 0.129 | 0.124 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 DBMET02076 0.172 0.011 DBMET02079 0.174 0.01 DBMET02080 0.131 0.116 DBMET02081 | DBMET02080 | |
| 0.108 | 0.103 | 0.133 | Calcium channel blocker | 0.114 0.094 DBMET02076 0.133 0.074 DBMET02079 | DBMET02079 | |
| 0.039 | 0.035 | 0.123 | Kainate receptor agonist | 0.056 0.009 DBMET02078 0.123 0.002 DBMET02079 0.057 0.009 DBMET02080 0.046 0.019 DBMET02081 0.042 0.027 DBMET02082 | DBMET02079 | |
| 0.019 | 0.017 | 0.107 | Retinoid X beta receptor agonist | 0.019 0.017 DBMET02076 0.025 0.01 DBMET02078 0.107 0.003 DBMET02079 0.022 0.013 DBMET02081 0.022 0.013 DBMET02082 | DBMET02079 | |
| 0.087 | 0.085 | 0.224 | Expectorant | 0.101 0.068 DBMET02076 0.112 0.057 DBMET02078 0.135 0.042 DBMET02079 0.224 0.016 DBMET02080 0.14 0.039 DBMET02082 0.092 0.079 DBMET02083 0.117 0.053 DBMET02084 | DBMET02080 | |
| 0.047 | 0.046 | 0.047 | Glucose-6-phosphate translocase inhibitor | |||
| 0.196 | 0.196 | 0.349 | Interleukin 2 agonist | 0.236 0.135 DBMET02076 0.254 0.114 DBMET02078 0.256 0.113 DBMET02079 0.349 0.046 DBMET02080 0.284 0.086 DBMET02081 0.282 0.087 DBMET02082 0.247 0.121 DBMET02083 0.287 0.083 DBMET02084 | DBMET02080 | |
| 0.035 | 0.035 | 0.137 | Membrane dipeptidase inhibitor | 0.054 0.013 DBMET02078 0.137 0.002 DBMET02079 0.061 0.01 DBMET02081 0.036 0.034 DBMET02082 0.036 0.034 DBMET02083 0.039 0.028 DBMET02084 | DBMET02079 | |
| 0.027 | 0.027 | 0.051 | Prostaglandin D2 agonist | 0.029 0.023 DBMET02076 0.035 0.017 DBMET02078 0.029 0.024 DBMET02079 0.051 0.007 DBMET02080 0.042 0.011 DBMET02081 0.034 0.018 DBMET02082 0.037 0.015 DBMET02084 | DBMET02080 | |
| 0.02 | 0.021 | 0.134 | Retinoic acid receptor agonist | 0.021 0.019 DBMET02076 0.033 0.008 DBMET02078 0.134 0.003 DBMET02079 0.056 0.005 DBMET02081 0.028 0.011 DBMET02082 0.024 0.015 DBMET02083 0.044 0.006 DBMET02084 | DBMET02079 | |
| 0.019 | 0.025 | 0.045 | Retinoic acid gamma receptor agonist | 0.021 0.02 DBMET02076 0.021 0.018 DBMET02078 0.045 0.004 DBMET02079 0.023 0.015 DBMET02081 0.03 0.006 DBMET02084 | DBMET02079 | |
| 0.105 | 0.11 | 0.182 | Lipid peroxidase inhibitor | 0.182 0.049 DBMET02080 | DBMET02080 | |
| 0.109 | 0.115 | 0.226 | Neurotrophic factor | 0.112 0.109 DBMET02076 0.123 0.09 DBMET02077 0.226 0.018 DBMET02080 | DBMET02080 | |
| 0.063 | 0.071 | 0.093 | CDC25A inhibitor | 0.069 0.059 DBMET02078 0.073 0.052 DBMET02079 0.093 0.032 DBMET02080 0.08 0.043 DBMET02082 | DBMET02080 | |
| 0.014 | 0.023 | 0.027 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.027 0.01 DBMET02080 | DBMET02080 | |
| 0.054 | 0.067 | 0.072 | Heme oxygenase stimulant | 0.072 0.023 DBMET02079 | DBMET02079 | |
| 0.018 | 0.033 | 0.051 | Leukotriene B4 receptor 1 antagonist | 0.049 0.007 DBMET02078 0.049 0.007 DBMET02079 0.051 0.007 DBMET02080 0.029 0.019 DBMET02081 0.045 0.009 DBMET02082 0.026 0.021 DBMET02083 0.027 0.02 DBMET02084 | DBMET02080 | |
| 0.016 | 0.033 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 DBMET02079 0.027 0.006 DBMET02080 | DBMET02080 | |
| 0.016 | 0.034 | 0.045 | Retinoid X beta receptor antagonist | 0.019 0.018 DBMET02078 0.045 0.003 DBMET02079 | DBMET02079 | |
| 0.038 | 0.057 | 0.08 | Protein 50S ribosomal subunit inhibitor | 0.062 0.03 DBMET02077 0.08 0.019 DBMET02080 | DBMET02080 | |
| 0.014 | 0.036 | 0.092 | Estrogen receptor beta agonist | 0.092 0.013 DBMET02080 | DBMET02080 | |
| 0.014 | 0.038 | 0.045 | Retinoic acid beta receptor agonist | 0.045 0.004 DBMET02079 0.025 0.008 DBMET02081 | DBMET02079 | |
| 0.001 | 0.025 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET02080 | DBMET02080 | |
| 0.019 | 0.047 | 0.041 | Prostaglandin agonist | 0.033 0.019 DBMET02079 0.041 0.013 DBMET02080 0.03 0.022 DBMET02081 0.036 0.016 DBMET02084 | DBMET02080 | |
| 0.049 | 0.078 | 0.06 | Lipocortins synthesis agonist | 0.057 0.043 DBMET02079 0.06 0.035 DBMET02080 0.055 0.05 DBMET02084 | DBMET02080 | |
| 0.033 | 0.063 | 0.067 | Neuraminidase (Influenza A) inhibitor | 0.058 0.014 DBMET02079 0.055 0.017 DBMET02080 0.067 0.008 DBMET02084 | DBMET02084 | |
| 0.011 | 0.041 | 0.016 | Vitamin D receptor agonist | 0.016 0.014 DBMET02079 0.016 0.012 DBMET02080 | DBMET02080 | |
| 0.011 | 0.043 | 0.05 | Retinoic acid alpha receptor antagonist | 0.05 0.004 DBMET02079 0.022 0.012 DBMET02081 | DBMET02079 | |
| 0.078 | 0.111 | 0.097 | Alpha 2d adrenoreceptor antagonist | 0.097 0.055 DBMET02080 | DBMET02080 | |
| 0.007 | 0.04 | 0.027 | Retinoic acid receptor gamma antagonist | 0.027 0.004 DBMET02079 0.012 0.008 DBMET02084 | DBMET02079 | |
| 0.123 | 0.157 | 0.228 | Lipocortins synthesis antagonist | 0.135 0.13 DBMET02076 0.153 0.1 DBMET02078 0.228 0.041 DBMET02079 0.188 0.065 DBMET02080 0.136 0.128 DBMET02081 0.138 0.125 DBMET02082 0.158 0.094 DBMET02083 0.16 0.092 DBMET02084 | DBMET02079 | |
| 0.01 | 0.044 | 0.052 | Retinoic acid receptor antagonist | 0.052 0.004 DBMET02079 0.023 0.009 DBMET02081 0.021 0.01 DBMET02084 | DBMET02079 | |
| 0.014 | 0.049 | 0.039 | Prostaglandin F2 alpha agonist | 0.039 0.006 DBMET02080 | DBMET02080 | |
| 0.05 | 0.086 | 0.113 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DBMET02076 0.074 0.031 DBMET02079 0.08 0.026 DBMET02080 0.113 0.013 DBMET02084 | DBMET02084 | |
| 0.005 | 0.044 | 0.028 | Retinoic acid beta receptor antagonist | 0.028 0.004 DBMET02079 | DBMET02079 | |
| 0.017 | 0.056 | 0.036 | Vanilloid 2 agonist | 0.026 0.015 DBMET02079 0.036 0.005 DBMET02080 | DBMET02080 | |
| 0.07 | 0.111 | 0.092 | Vanilloid agonist | 0.092 0.043 DBMET02080 | DBMET02080 | |
| 0.083 | 0.13 | 0.165 | Photosensitizer | 0.165 0.023 DBMET02079 0.133 0.043 DBMET02080 | DBMET02079 | |
| 0.016 | 0.064 | 0.062 | Vitamin D receptor antagonist | 0.062 0.004 DBMET02080 | DBMET02080 | |
| 0.006 | 0.055 | 0.017 | Prostacyclin agonist | 0.017 0.01 DBMET02079 0.015 0.011 DBMET02084 | DBMET02079 | |
| 0.022 | 0.074 | 0.059 | Retinoid X alpha receptor antagonist | 0.059 0.004 DBMET02079 | DBMET02079 | |
| 0.011 | 0.064 | 0.049 | Leukotriene B4 receptor 2 antagonist | 0.032 0.008 DBMET02078 0.049 0.004 DBMET02079 0.021 0.017 DBMET02080 0.029 0.009 DBMET02082 0.028 0.01 DBMET02084 | DBMET02079 | |
| 0.024 | 0.081 | 0.067 | Retinoid X receptor antagonist | 0.067 0.004 DBMET02079 | DBMET02079 | |
| 0.028 | 0.091 | 0.102 | Adenylate cyclase 1 inhibitor | 0.102 0.004 DBMET02080 | DBMET02080 | |
| 0.006 | 0.071 | 0.061 | Estrogen receptor alpha agonist | 0.061 0.015 DBMET02080 | DBMET02080 | |
| 0.003 | 0.069 | 0.012 | Thromboxane agonist | 0.012 0.007 DBMET02079 0.01 0.009 DBMET02080 | DBMET02079 | |
| 0.106 | 0.172 | 0.417 | Anesthetic general | 0.417 0.014 DBMET02080 | DBMET02080 | |
| 0.158 | 0.227 | 0.475 | Angiogenesis inhibitor | 0.475 0.034 DBMET02082 | DBMET02082 | |
| 0.099 | 0.17 | 0.248 | Psychostimulant | 0.134 0.132 DBMET02079 0.248 0.059 DBMET02080 | DBMET02080 | |
| 0.031 | 0.104 | 0.071 | Leukotriene B4 antagonist | 0.057 0.032 DBMET02078 0.071 0.019 DBMET02079 0.067 0.021 DBMET02080 0.053 0.039 DBMET02082 | DBMET02079 | |
| 0.05 | 0.123 | 0.137 | Glycine receptor agonist | 0.137 0.009 DBMET02079 0.1 0.021 DBMET02080 | DBMET02079 | |
| 0.007 | 0.081 | 0.021 | Prostaglandin E2 agonist | 0.021 0.019 DBMET02080 | DBMET02080 | |
| 0.013 | 0.088 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 DBMET02079 0.025 0.021 DBMET02080 | DBMET02079 | |
| 0.029 | 0.106 | 0.056 | Aldosterone antagonist | 0.056 0.022 DBMET02080 | DBMET02080 | |
| 0.008 | 0.084 | 0.017 | Telomerase stimulant | 0.017 0.011 DBMET02079 0.017 0.013 DBMET02080 | DBMET02080 | |
| 0.064 | 0.142 | 0.176 | ABCA1 expression enhancer | 0.085 0.075 DBMET02077 0.176 0.012 DBMET02079 0.087 0.071 DBMET02084 | DBMET02079 | |
| 0.063 | 0.145 | 0.138 | Estrogen receptor beta antagonist | 0.138 0.019 DBMET02080 | DBMET02080 | |
| 0.061 | 0.145 | 0.118 | Anesthetic local | 0.118 0.069 DBMET02080 | DBMET02080 | |
| 0.14 | 0.225 | 0.254 | Peptidyltransferase inhibitor | 0.2 0.099 DBMET02076 0.175 0.137 DBMET02078 0.191 0.111 DBMET02079 0.254 0.048 DBMET02080 0.225 0.071 DBMET02081 0.182 0.124 DBMET02084 | DBMET02080 | |
| 0.047 | 0.136 | 0.175 | Monophenol monooxygenase inhibitor | 0.175 0.039 DBMET02080 | DBMET02080 | |
| 0.062 | 0.156 | 0.166 | DNA polymerase I inhibitor | 0.166 0.041 DBMET02079 0.138 0.056 DBMET02082 0.117 0.071 DBMET02084 | DBMET02079 | |
| 0.142 | 0.237 | 0.27 | Gastrin inhibitor | 0.27 0.057 DBMET02079 0.232 0.103 DBMET02080 | DBMET02079 | |
| 0.018 | 0.118 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.039 0.022 DBMET02080 | DBMET02080 | |
| 0.058 | 0.162 | 0.128 | Bile acid receptor antagonist | 0.087 0.08 DBMET02078 0.128 0.014 DBMET02079 0.11 0.031 DBMET02080 0.097 0.055 DBMET02082 | DBMET02079 | |
| 0.065 | 0.17 | 0.163 | Toll-Like receptor 4 antagonist | 0.138 0.028 DBMET02078 0.163 0.015 DBMET02079 0.091 0.086 DBMET02080 0.137 0.029 DBMET02081 0.138 0.028 DBMET02082 0.109 0.056 DBMET02083 0.125 0.039 DBMET02084 | DBMET02079 | |
| 0.049 | 0.153 | 0.115 | Inducible nitric-oxide synthase inhibitor | 0.115 0.027 DBMET02080 | DBMET02080 | |
| 0.033 | 0.14 | 0.069 | Dihydroorotate oxidase inhibitor | 0.056 0.037 DBMET02079 0.069 0.018 DBMET02080 | DBMET02080 | |
| 0.014 | 0.122 | 0.031 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET02079 0.029 0.026 DBMET02080 | DBMET02079 | |
| 0.006 | 0.118 | 0.019 | Prostaglandin EP2 agonist | 0.019 0.018 DBMET02079 | DBMET02079 | |
| 0.088 | 0.202 | 0.152 | Growth hormone agonist | 0.122 0.118 DBMET02079 0.152 0.086 DBMET02080 | DBMET02080 | |
| 0.1 | 0.221 | 0.465 | Platelet antagonist | 0.204 0.098 DBMET02076 0.217 0.09 DBMET02078 0.27 0.064 DBMET02079 0.18 0.117 DBMET02080 0.19 0.109 DBMET02081 0.465 0.018 DBMET02082 0.182 0.115 DBMET02083 0.194 0.106 DBMET02084 | DBMET02082 | |
| 0.051 | 0.172 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET02080 0.115 0.023 DBMET02083 | DBMET02083 | |
| 0.104 | 0.227 | 0.331 | Succinate dehydrogenase inhibitor | 0.158 0.098 DBMET02078 0.331 0.007 DBMET02079 0.203 0.046 DBMET02080 0.147 0.119 DBMET02081 0.151 0.11 DBMET02084 | DBMET02079 | |
| 0.009 | 0.135 | 0.029 | Prostaglandin EP4 antagonist | 0.029 0.016 DBMET02080 | DBMET02080 | |
| 0.06 | 0.192 | 0.104 | 3C-Like protease (SARS coronavirus) inhibitor | 0.104 0.029 DBMET02077 | DBMET02077 | |
| 0.054 | 0.188 | 0.18 | Interleukin 5 antagonist | 0.097 0.045 DBMET02080 0.18 0.007 DBMET02081 | DBMET02081 | |
| 0.015 | 0.15 | 0.074 | Aromatase inhibitor | 0.074 0.031 DBMET02080 | DBMET02080 | |
| 0.005 | 0.14 | 0.016 | Thromboxane A2 agonist | 0.016 0.01 DBMET02080 | DBMET02080 | |
| 0.043 | 0.18 | 0.179 | Keratolytic | 0.179 0.01 DBMET02079 0.087 0.041 DBMET02080 0.076 0.055 DBMET02084 | DBMET02079 | |
| 0.057 | 0.194 | 0.097 | Ca(v)3.1 blocker | 0.083 0.052 DBMET02076 0.097 0.026 DBMET02077 | DBMET02077 | |
| 0.127 | 0.265 | 0.223 | RNA-directed DNA polymerase inhibitor | 0.198 0.103 DBMET02079 0.223 0.071 DBMET02080 | DBMET02080 | |
| 0.041 | 0.18 | 0.075 | Exportin-1 inhibitor | 0.075 0.033 DBMET02080 | DBMET02080 | |
| 0.068 | 0.214 | 0.177 | Angiogenesis stimulant | 0.177 0.107 DBMET02082 | DBMET02082 | |
| 0.035 | 0.188 | 0.158 | GABA aminotransferase inhibitor | 0.158 0.007 DBMET02079 0.1 0.027 DBMET02080 | DBMET02079 | |
| 0.061 | 0.217 | 0.163 | Adenylate kinase inhibitor | 0.155 0.024 DBMET02079 0.163 0.022 DBMET02080 | DBMET02080 | |
| 0.02 | 0.18 | 0.154 | Phosphofructokinase-1 inhibitor | 0.149 0.018 DBMET02079 0.154 0.017 DBMET02080 | DBMET02080 | |
| 0.047 | 0.208 | 0.249 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.249 0.01 DBMET02079 0.129 0.034 DBMET02080 | DBMET02079 | |
| 0.028 | 0.189 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.037 DBMET02079 | DBMET02079 | |
| 0.014 | 0.177 | 0.053 | Prostaglandin E2 antagonist | 0.053 0.033 DBMET02080 | DBMET02080 | |
| 0.015 | 0.182 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET02080 | DBMET02080 | |
| 0.029 | 0.197 | 0.212 | Androgen antagonist | 0.212 0.012 DBMET02080 | DBMET02080 | |
| 0.013 | 0.181 | 0.048 | Potassium channel Kv1.3 blocker | 0.048 0.032 DBMET02080 | DBMET02080 | |
| 0.037 | 0.209 | 0.118 | 5-Lipoxygenase inhibitor | 0.085 0.076 DBMET02078 0.095 0.067 DBMET02079 0.118 0.051 DBMET02080 | DBMET02080 | |
| 0.078 | 0.257 | 0.177 | Hemostatic | 0.122 0.11 DBMET02079 0.177 0.044 DBMET02080 | DBMET02080 | |
| 0.039 | 0.219 | 0.124 | Glutamate (mGluR6) antagonist | 0.124 0.005 DBMET02079 0.076 0.03 DBMET02080 | DBMET02079 | |
| 0.023 | 0.205 | 0.141 | Lipase inhibitor | 0.141 0.011 DBMET02077 | DBMET02077 | |
| 0.108 | 0.292 | 0.279 | 5 Hydroxytryptamine release stimulant | 0.216 0.109 DBMET02079 0.279 0.077 DBMET02080 | DBMET02080 | |
| 0.018 | 0.204 | 0.148 | Biliverdin reductase inhibitor | 0.148 0.01 DBMET02079 0.111 0.016 DBMET02080 | DBMET02079 | |
| 0.141 | 0.329 | 0.286 | 5 Hydroxytryptamine uptake stimulant | 0.246 0.085 DBMET02079 0.286 0.052 DBMET02080 | DBMET02080 | |
| 0.081 | 0.273 | 0.215 | Non-steroidal antiinflammatory agent | 0.165 0.099 DBMET02078 0.215 0.06 DBMET02079 0.204 0.068 DBMET02080 0.176 0.09 DBMET02082 | DBMET02079 | |
| 0.019 | 0.213 | 0.082 | Leukotriene antagonist | 0.082 0.031 DBMET02079 0.066 0.044 DBMET02080 | DBMET02079 | |
| 0.007 | 0.202 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET02080 | DBMET02080 | |
| 0.023 | 0.224 | 0.091 | CDC25B inhibitor | 0.091 0.02 DBMET02077 0.063 0.046 DBMET02079 | DBMET02077 | |
| 0.044 | 0.247 | 0.105 | Cyclooxygenase 1 inhibitor | 0.105 0.095 DBMET02080 | DBMET02080 | |
| 0.014 | 0.22 | 0.098 | Acyl-CoA dehydrogenase inhibitor | 0.098 0.017 DBMET02079 0.071 0.026 DBMET02080 | DBMET02079 | |
| 0.005 | 0.21 | 0.051 | Progesterone antagonist | 0.051 0.018 DBMET02080 | DBMET02080 | |
| 0.046 | 0.254 | 0.147 | Adenylate cyclase inhibitor | 0.147 0.047 DBMET02080 | DBMET02080 | |
| 0.042 | 0.25 | 0.174 | Triose-phosphate isomerase inhibitor | 0.153 0.019 DBMET02079 0.174 0.014 DBMET02080 0.086 0.066 DBMET02084 | DBMET02080 | |
| 0.007 | 0.217 | 0.082 | Fumarate hydratase inhibitor | 0.082 0.007 DBMET02079 0.033 0.025 DBMET02080 | DBMET02079 | |
| 0.073 | 0.285 | 0.221 | Interleukin 6 antagonist | 0.144 0.099 DBMET02080 0.221 0.031 DBMET02084 | DBMET02084 | |
| 0.02 | 0.233 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET02079 0.065 0.015 DBMET02080 | DBMET02080 | |
| 0.019 | 0.236 | 0.08 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.08 0.016 DBMET02080 | DBMET02080 | |
| 0.11 | 0.327 | 0.263 | Vasodilator, peripheral | 0.225 0.149 DBMET02079 0.263 0.118 DBMET02080 0.191 0.187 DBMET02084 | DBMET02080 | |
| 0.037 | 0.255 | 0.347 | Ferrochelatase inhibitor | 0.347 0.005 DBMET02079 0.151 0.037 DBMET02080 | DBMET02079 | |
| 0.037 | 0.26 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET02080 | DBMET02080 | |
| 0.022 | 0.256 | 0.053 | Fatty acid synthase inhibitor | 0.053 0.045 DBMET02080 | DBMET02080 | |
| 0.079 | 0.317 | 0.223 | Neurotrophic factor enhancer | 0.168 0.112 DBMET02079 0.223 0.057 DBMET02080 | DBMET02080 | |
| 0.008 | 0.247 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 DBMET02079 | DBMET02079 | |
| 0.01 | 0.25 | 0.067 | GABA uptake inhibitor | 0.067 0.008 DBMET02079 | DBMET02079 | |
| 0.119 | 0.361 | 0.426 | GABA C receptor rho-3 antagonist | 0.249 0.155 DBMET02079 0.426 0.051 DBMET02080 | DBMET02080 | |
| 0.057 | 0.3 | 0.15 | Farnesoid X receptor antagonist | 0.15 0.052 DBMET02079 0.149 0.053 DBMET02080 0.119 0.106 DBMET02082 | DBMET02079 | |
| 0.007 | 0.251 | 0.041 | CYP24 inhibitor | 0.041 0.007 DBMET02080 | DBMET02080 | |
| 0.053 | 0.297 | 0.139 | Glutamate release inhibitor | 0.139 0.013 DBMET02079 | DBMET02079 | |
| 0.008 | 0.252 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 DBMET02079 | DBMET02079 | |
| 0.029 | 0.275 | 0.114 | Glutamate dehydrogenase inhibitor | 0.114 0.025 DBMET02079 0.11 0.026 DBMET02080 | DBMET02079 | |
| 0.001 | 0.247 | 0.011 | Mannitol 2-dehydrogenase inhibitor | 0.011 0.004 DBMET02084 | DBMET02084 | |
| 0.02 | 0.269 | 0.039 | Leukotriene C4 antagonist | 0.039 0.028 DBMET02079 | DBMET02079 | |
| 0.064 | 0.315 | 0.101 | Interleukin 2 antagonist | 0.101 0.09 DBMET02080 | DBMET02080 | |
| 0.001 | 0.257 | 0.018 | Glutamate (mGluR6) agonist | 0.018 0.005 DBMET02079 | DBMET02079 | |
| 0.024 | 0.281 | 0.081 | Parathyroid hormone antagonist | 0.081 0.005 DBMET02080 | DBMET02080 | |
| 0.029 | 0.288 | 0.09 | Mediator release inhibitor | 0.09 0.081 DBMET02080 | DBMET02080 | |
| 0.029 | 0.291 | 0.059 | Leukotriene C antagonist | 0.059 0.031 DBMET02079 | DBMET02079 | |
| 0.112 | 0.379 | 0.376 | Histamine release inhibitor | 0.376 0.088 DBMET02079 0.373 0.089 DBMET02080 | DBMET02079 | |
| 0.015 | 0.287 | 0.066 | Glutamate (mGluR8) agonist | 0.066 0.005 DBMET02079 | DBMET02079 | |
| 0.016 | 0.288 | 0.196 | Aconitate hydratase inhibitor | 0.196 0.003 DBMET02079 | DBMET02079 | |
| 0.032 | 0.304 | 0.435 | GABA C receptor agonist | 0.435 0.004 DBMET02079 0.141 0.038 DBMET02080 | DBMET02079 | |
| 0.075 | 0.352 | 0.219 | ATPase inhibitor | 0.219 0.024 DBMET02080 | DBMET02080 | |
| 0.033 | 0.31 | 0.074 | Glutathione S-transferase inhibitor | 0.074 0.072 DBMET02080 | DBMET02080 | |
| 0.038 | 0.316 | 0.422 | Alpha-N-acetylglucosaminidase inhibitor | 0.422 0.008 DBMET02079 0.246 0.024 DBMET02080 0.156 0.052 DBMET02084 | DBMET02079 | |
| 0.004 | 0.285 | 0.02 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.017 DBMET02080 | DBMET02080 | |
| 0.005 | 0.286 | 0.042 | Farnesoid X receptor agonist | 0.042 0.021 DBMET02079 | DBMET02079 | |
| 0.011 | 0.294 | 0.089 | Argininosuccinate synthase inhibitor | 0.089 0.022 DBMET02079 0.069 0.031 DBMET02080 | DBMET02079 | |
| 0.01 | 0.293 | 0.079 | HIV-1 integrase (Strand Transfer) inhibitor | 0.079 0.032 DBMET02079 | DBMET02079 | |
| 0.007 | 0.293 | 0.052 | Inosine monophosphate dehydrogenase inhibitor | 0.052 0.014 DBMET02080 | DBMET02080 | |
| 0.011 | 0.303 | 0.047 | Glutamate (mGluR3) agonist | 0.047 0.006 DBMET02079 | DBMET02079 | |
| 0.007 | 0.3 | 0.054 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 DBMET02079 0.05 0.039 DBMET02080 | DBMET02079 | |
| 0.037 | 0.334 | 0.205 | Bone formation stimulant | 0.205 0.034 DBMET02080 0.108 0.097 DBMET02081 | DBMET02080 | |
| 0.066 | 0.369 | 0.182 | 5 Hydroxytryptamine 1E antagonist | 0.182 0.151 DBMET02080 | DBMET02080 | |
| 0.007 | 0.311 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 DBMET02079 | DBMET02079 | |
| 0.075 | 0.381 | 0.272 | Superoxide dismutase inhibitor | 0.272 0.062 DBMET02079 0.231 0.088 DBMET02080 | DBMET02079 | |
| 0.006 | 0.313 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET02080 | DBMET02080 | |
| 0.028 | 0.34 | 0.133 | GABA C receptor antagonist | 0.122 0.05 DBMET02079 0.133 0.041 DBMET02080 | DBMET02080 | |
| 0.078 | 0.395 | 0.378 | Hypoxia-inducible factor 1 alpha inhibitor | 0.378 0.036 DBMET02080 | DBMET02080 | |
| 0.055 | 0.374 | 0.159 | GABA C receptor rho-2 antagonist | 0.159 0.062 DBMET02080 | DBMET02080 | |
| 0.044 | 0.365 | 0.198 | Insulin sensitizer | 0.198 0.075 DBMET02079 0.183 0.092 DBMET02080 | DBMET02079 | |
| 0.014 | 0.337 | 0.195 | Porphobilinogen synthase inhibitor | 0.195 0.013 DBMET02079 0.103 0.034 DBMET02080 | DBMET02079 | |
| 0.007 | 0.33 | 0.071 | Thromboxane A2 antagonist | 0.071 0.021 DBMET02079 | DBMET02079 | |
| 0.034 | 0.357 | 0.146 | Electrolyte absorption antagonist | 0.146 0.021 DBMET02079 | DBMET02079 | |
| 0.019 | 0.342 | 0.059 | Prostaglandin F2 alpha antagonist | 0.059 0.048 DBMET02079 | DBMET02079 | |
| 0.004 | 0.33 | 0.04 | Estradiol 17 beta-dehydrogenase inhibitor | 0.04 0.031 DBMET02080 | DBMET02080 | |
| 0.027 | 0.357 | 0.154 | UDP-glucose 4-epimerase inhibitor | 0.104 0.056 DBMET02079 0.154 0.028 DBMET02080 | DBMET02080 | |
| 0.033 | 0.364 | 0.174 | Amylase inhibitor | 0.127 0.076 DBMET02079 0.174 0.054 DBMET02080 | DBMET02080 | |
| 0.015 | 0.346 | 0.079 | Glutamate (mGluR8) antagonist | 0.079 0.004 DBMET02079 | DBMET02079 | |
| 0.038 | 0.37 | 0.12 | Toll-Like receptor 2 antagonist | 0.12 0.078 DBMET02080 | DBMET02080 | |
| 0.064 | 0.398 | 0.184 | Phospholipase C inhibitor | 0.183 0.058 DBMET02079 0.184 0.057 DBMET02080 | DBMET02080 | |
| 0.008 | 0.35 | 0.075 | Thromboxane antagonist | 0.075 0.023 DBMET02079 | DBMET02079 | |
| 0.009 | 0.352 | 0.084 | Peroxisome proliferator-activated receptor gamma agonist | 0.084 0.038 DBMET02079 0.077 0.043 DBMET02084 | DBMET02079 | |
| 0.013 | 0.364 | 0.124 | Glutamate decarboxylase inhibitor | 0.124 0.019 DBMET02079 0.076 0.048 DBMET02080 | DBMET02079 | |
| 0.029 | 0.381 | 0.116 | GABA C receptor rho-1 antagonist | 0.089 0.08 DBMET02079 0.116 0.044 DBMET02080 | DBMET02080 | |
| 0.125 | 0.487 | 0.271 | Calcium channel L-type activator | 0.235 0.222 DBMET02080 0.271 0.184 DBMET02081 | DBMET02081 | |
| 0.083 | 0.447 | 0.323 | Sodium/bile acid cotransporter inhibitor | 0.323 0.06 DBMET02079 0.229 0.152 DBMET02080 0.202 0.185 DBMET02081 0.247 0.131 DBMET02084 | DBMET02079 | |
| 0.005 | 0.37 | 0.07 | CXC chemokine 3 receptor antagonist | 0.07 0.005 DBMET02079 | DBMET02079 | |
| 0.003 | 0.373 | 0.026 | Uridine phosphorylase inhibitor | 0.026 0.021 DBMET02080 | DBMET02080 | |
| 0.055 | 0.425 | 0.253 | Lipoxygenase inhibitor | 0.253 0.098 DBMET02080 | DBMET02080 | |
| 0.009 | 0.38 | 0.075 | HIV-1 integrase (3'-Processing) inhibitor | 0.075 0.036 DBMET02079 | DBMET02079 | |
| 0.036 | 0.408 | 0.103 | Aldehyde dehydrogenase inhibitor | 0.103 0.092 DBMET02079 | DBMET02079 | |
| 0.002 | 0.378 | 0.052 | Kainate receptor 1 antagonist | 0.052 0.005 DBMET02079 | DBMET02079 | |
| 0.011 | 0.388 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 DBMET02080 | DBMET02080 | |
| 0.033 | 0.411 | 0.145 | Phospholipase A2 inhibitor | 0.145 0.079 DBMET02079 | DBMET02079 | |
| 0.008 | 0.396 | 0.106 | Alcohol oxidase inhibitor | 0.106 0.017 DBMET02079 0.073 0.027 DBMET02080 | DBMET02079 | |
| 0.054 | 0.444 | 0.172 | CF transmembrane conductance regulator agonist | 0.172 0.045 DBMET02080 | DBMET02080 | |
| 0.025 | 0.415 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 DBMET02079 | DBMET02079 | |
| 0.012 | 0.406 | 0.04 | Thymidine kinase inhibitor | 0.04 0.03 DBMET02080 | DBMET02080 | |
| 0.02 | 0.414 | 0.086 | Nitric-oxide synthase inhibitor | 0.086 0.085 DBMET02080 | DBMET02080 | |
| 0.017 | 0.419 | 0.098 | Alkylator | 0.098 0.091 DBMET02079 | DBMET02079 | |
| 0.007 | 0.411 | 0.045 | Glutamate (mGluR1) agonist | 0.045 0.005 DBMET02079 | DBMET02079 | |
| 0.02 | 0.426 | 0.131 | Cystathionine beta-synthase inhibitor | 0.131 0.051 DBMET02079 0.119 0.059 DBMET02080 | DBMET02079 | |
| 0.089 | 0.503 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.055 DBMET02079 0.139 0.077 DBMET02080 | DBMET02079 | |
| 0.018 | 0.435 | 0.061 | Purinergic P2X1 antagonist | 0.061 0.041 DBMET02079 | DBMET02079 | |
| 0.029 | 0.447 | 0.115 | NADH dehydrogenase inhibitor | 0.115 0.032 DBMET02079 0.107 0.038 DBMET02080 | DBMET02079 | |
| 0.004 | 0.427 | 0.048 | Peroxisome proliferator-activated receptor alpha agonist | 0.048 0.033 DBMET02079 | DBMET02079 | |
| 0.017 | 0.441 | 0.1 | Peroxisome proliferator-activated receptor gamma antagonist | 0.1 0.015 DBMET02079 | DBMET02079 | |
| 0.013 | 0.443 | 0.095 | Aminopeptidase I inhibitor | 0.095 0.031 DBMET02079 | DBMET02079 | |
| 0.002 | 0.438 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET02079 | DBMET02079 | |
| 0.003 | 0.448 | 0.08 | Kainate receptor antagonist | 0.08 0.01 DBMET02079 | DBMET02079 | |
| 0.084 | 0.534 | 0.25 | Tyrosine 3 hydroxylase inhibitor | 0.25 0.068 DBMET02079 0.226 0.095 DBMET02080 | DBMET02079 | |
| 0.009 | 0.475 | 0.059 | Sphingosine kinase inhibitor | 0.059 0.041 DBMET02080 | DBMET02080 | |
| 0.047 | 0.513 | 0.346 | 15-Lipoxygenase inhibitor | 0.346 0.102 DBMET02080 | DBMET02080 | |
| 0.023 | 0.49 | 0.104 | Cathepsin H inhibitor | 0.104 0.099 DBMET02079 | DBMET02079 | |
| 0.007 | 0.475 | 0.065 | Carbamoyl phosphate synthetase inhibitor | 0.065 0.038 DBMET02079 0.064 0.039 DBMET02080 | DBMET02079 | |
| 0.036 | 0.504 | 0.141 | Pregnane X receptor agonist | 0.141 0.071 DBMET02080 | DBMET02080 | |
| 0.026 | 0.505 | 0.127 | DOPA decarboxylase inhibitor | 0.127 0.038 DBMET02079 | DBMET02079 | |
| 0.036 | 0.525 | 0.26 | Interleukin agonist | 0.202 0.119 DBMET02079 0.26 0.072 DBMET02080 | DBMET02080 | |
| 0.009 | 0.504 | 0.057 | Sphingosine kinase 2 inhibitor | 0.057 0.035 DBMET02080 | DBMET02080 | |
| 0.012 | 0.511 | 0.088 | Phospholipase D inhibitor | 0.088 0.024 DBMET02079 | DBMET02079 | |
| 0.011 | 0.51 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.033 DBMET02079 | DBMET02079 | |
| 0.066 | 0.58 | 0.47 | Cyclophilin D inhibitor | 0.392 0.095 DBMET02079 0.331 0.137 DBMET02083 0.47 0.06 DBMET02084 | DBMET02084 | |
| 0.001 | 0.52 | 0.023 | Prostaglandin H2 antagonist | 0.023 0.02 DBMET02079 | DBMET02079 | |
| 0.008 | 0.531 | 0.068 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.048 DBMET02079 | DBMET02079 | |
| 0.034 | 0.569 | 0.174 | DNA damaging | 0.174 0.141 DBMET02080 | DBMET02080 | |
| 0.032 | 0.569 | 0.286 | Interleukin 4 antagonist | 0.143 0.056 DBMET02080 0.286 0.01 DBMET02081 | DBMET02081 | |
| 0.011 | 0.549 | 0.079 | Glutamate (mGluR7) antagonist | 0.079 0.029 DBMET02079 | DBMET02079 | |
| 0.003 | 0.546 | 0.06 | Kainate receptor 2 antagonist | 0.06 0.012 DBMET02079 | DBMET02079 | |
| 0.069 | 0.616 | 0.393 | 5 Hydroxytryptamine release inhibitor | 0.393 0.082 DBMET02079 0.243 0.238 DBMET02080 | DBMET02079 | |
| 0.016 | 0.566 | 0.133 | Aminopeptidase B inhibitor | 0.133 0.046 DBMET02079 | DBMET02079 | |
| 0.021 | 0.573 | 0.066 | MDM2 inhibitor | 0.066 0.05 DBMET02079 | DBMET02079 | |
| 0.005 | 0.56 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET02079 | DBMET02079 | |
| 0.021 | 0.579 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DBMET02080 | DBMET02080 | |
| 0.002 | 0.563 | 0.041 | Free fatty acid receptor 1 antagonist | 0.041 0.015 DBMET02079 | DBMET02079 | |
| 0.013 | 0.579 | 0.11 | Creatine kinase inhibitor | 0.094 0.066 DBMET02079 0.11 0.049 DBMET02080 | DBMET02080 | |
| 0.026 | 0.603 | 0.221 | Calpain 2 inhibitor | 0.221 0.171 DBMET02079 | DBMET02079 | |
| 0.002 | 0.585 | 0.028 | Kynurenine 3 monooxygenase inhibitor | 0.028 0.017 DBMET02079 | DBMET02079 | |
| 0.023 | 0.608 | 0.179 | Insulin secretagoues | 0.179 0.048 DBMET02079 | DBMET02079 | |
| 0.094 | 0.683 | 0.329 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.329 0.176 DBMET02079 | DBMET02079 | |
| 0.026 | 0.616 | 0.155 | Tumour necrosis factor alpha release inhibitor | 0.155 0.152 DBMET02080 | DBMET02080 | |
| 0.018 | 0.609 | 0.172 | Calpain inhibitor | 0.172 0.145 DBMET02079 | DBMET02079 | |
| 0.002 | 0.599 | 0.026 | Glutamate (mGluR1a) agonist | 0.026 0.011 DBMET02079 | DBMET02079 | |
| 0.006 | 0.611 | 0.048 | Diacylglycerol O-acyltransferase inhibitor | 0.048 0.04 DBMET02079 | DBMET02079 | |
| 0.006 | 0.618 | 0.072 | Thromboxane synthase inhibitor | 0.072 0.016 DBMET02079 | DBMET02079 | |
| 0.008 | 0.623 | 0.108 | NMDA receptor agonist | 0.108 0.016 DBMET02079 | DBMET02079 | |
| 0.018 | 0.644 | 0.128 | Sphingosine 1-phosphate receptor 4 antagonist | 0.128 0.059 DBMET02079 | DBMET02079 | |
| 0.022 | 0.651 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.145 DBMET02079 0.156 0.136 DBMET02080 | DBMET02080 | |
| 0.003 | 0.638 | 0.024 | Angiotensin AT2 receptor antagonist | 0.024 0.014 DBMET02079 | DBMET02079 | |
| 0.004 | 0.642 | 0.074 | NMDA receptor glycine site agonist | 0.074 0.033 DBMET02079 | DBMET02079 | |
| 0.005 | 0.648 | 0.069 | Catalase inhibitor | 0.069 0.055 DBMET02079 | DBMET02079 | |
| 0.019 | 0.663 | 0.222 | Aldehyde oxidase inhibitor | 0.222 0.094 DBMET02079 0.152 0.137 DBMET02080 | DBMET02079 | |
| 0.003 | 0.647 | 0.037 | Sphingosine 1-phosphate receptor 3 agonist | 0.037 0.023 DBMET02079 | DBMET02079 | |
| 0.031 | 0.685 | 0.151 | Neurotensin receptor agonist | 0.151 0.099 DBMET02079 | DBMET02079 | |
| 0.061 | 0.716 | 0.189 | Nitric-oxide synthase stimulant | 0.189 0.109 DBMET02080 | DBMET02080 | |
| 0.003 | 0.659 | 0.047 | Glutamate (mGluR3) antagonist | 0.047 0.014 DBMET02079 | DBMET02079 | |
| 0.004 | 0.671 | 0.07 | AMPA 4 receptor antagonist | 0.07 0.008 DBMET02079 | DBMET02079 | |
| 0.001 | 0.675 | 0.012 | Thrombopoietin agonist | 0.012 0.007 DBMET02079 | DBMET02079 | |
| 0.007 | 0.727 | 0.093 | GABA receptor agonist | 0.093 0.085 DBMET02079 | DBMET02079 | |
| 0.012 | 0.734 | 0.348 | Interleukin antagonist | 0.348 0.039 DBMET02081 | DBMET02081 | |
| 0.002 | 0.741 | 0.033 | AMPA 3 receptor antagonist | 0.033 0.018 DBMET02079 | DBMET02079 | |
| 0.005 | 0.757 | 0.06 | Glutamate (mGluR group III) antagonist | 0.06 0.013 DBMET02079 | DBMET02079 | |
| 0.01 | 0.764 | 0.132 | Thrombolytic | 0.132 0.097 DBMET02079 | DBMET02079 | |
| 0.011 | 0.776 | 0.173 | Cell wall synthesis inhibitor | 0.173 0.045 DBMET02079 | DBMET02079 | |
| 0.007 | 0.787 | 0.054 | Glutamate (mGluR4) antagonist | 0.054 0.017 DBMET02079 | DBMET02079 | |
| 0.006 | 0.795 | 0.073 | GABA B receptor agonist | 0.073 0.06 DBMET02079 | DBMET02079 | |
| 0.009 | 0.811 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | 0.155 0.054 DBMET02079 | DBMET02079 | |
| 0.009 | 0.814 | 0.48 | Dual specificity phosphatase inhibitor | 0.48 0.007 DBMET02081 | DBMET02081 | |
| 0.009 | 0.836 | 0.122 | Interleukin 1 antagonist | 0.122 0.085 DBMET02079 | DBMET02079 | |
| 0.003 | 0.851 | 0.029 | Endothelin receptor antagonist | 0.029 0.019 DBMET02079 | DBMET02079 | |
| 0.005 | 0.86 | 0.067 | Sphingosine 1-phosphate receptor 5 agonist | 0.067 0.019 DBMET02079 | DBMET02079 | |
| 0.012 | 0.878 | 0.345 | Immunomodulator | 0.345 0.061 DBMET02080 | DBMET02080 | |
| 0.002 | 0.873 | 0.099 | Glutamate receptor agonist | 0.099 0.038 DBMET02079 | DBMET02079 | |
| 0.005 | 0.91 | 0.13 | Anticoagulant | 0.13 0.1 DBMET02082 | DBMET02082 | |
| 0.002 | 0.91 | 0.021 | Angiotensin AT1A receptor antagonist | 0.021 0.017 DBMET02079 | DBMET02079 | |
| 0.004 | 0.912 | 0.127 | M17 leucyl aminopeptidase inhibitor | 0.127 0.072 DBMET02079 | DBMET02079 | |
| 0.003 | 0.915 | 0.038 | AMPA 2 receptor antagonist | 0.038 0.015 DBMET02079 | DBMET02079 | |
| 0.017 | 0.975 | 0.135 | Factor V inhibitor | 0.135 0.027 DBMET02077 | DBMET02077 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |